Greenwich LifeSciences, Inc. (GLSI)
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Net income
- -$19.4M
- Total assets
- $6.2M
- Market cap
- $190.5M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $190.5M
- Shares outstanding
- 10.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 25, 2020
Greenwich LifeSciences, Inc. (GLSI) Stock Price
- Reported a net loss of $19.4M.
- Trading 48% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Greenwich LifeSciences, Inc..
Write a review
News about Greenwich LifeSciences, Inc.
News & sentiment via Polygon.io
Greenwich LifeSciences, Inc.: frequently asked questions
Is Greenwich LifeSciences, Inc. an American company?
Greenwich LifeSciences, Inc. is a US-based company headquartered in Stafford, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Greenwich LifeSciences, Inc. headquartered?
Greenwich LifeSciences, Inc. is headquartered in Stafford, Texas, United States.
Is Greenwich LifeSciences, Inc. publicly traded?
Yes — Greenwich LifeSciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol GLSI on the NASDAQ.
What does Greenwich LifeSciences, Inc. do?
Greenwich LifeSciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
